LEP and cancer: The study is one of the few that has measurements for a range of biomarkers reflecting the three pathways discussed above, including inflammatory biomarkers (including leptin and C‐reactive protein (CRP)), fasting levels of insulin, and estradiol, and provides a unique resource for quantifying and comparing the role of these biomarkers in explaining the effect of adiposity on the three cancers.